cysteine has been researched along with Cognition Disorders in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.56) | 18.2507 |
| 2000's | 18 (46.15) | 29.6817 |
| 2010's | 20 (51.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CC; Chong, MY; Hsu, ST; Huang, YC; Hung, CF; Lee, Y; Lin, CH; Lin, PY; Wang, LJ; Wu, CC | 1 |
| Abo, M; Hara, T; Kawakami, K; Kenmoku, M; Niimi, M; Saito, R; Sasaki, N; Yamada, N | 1 |
| Hayashi, S; Ikeda, C; Nagao, S; Oshima, E; Sato, S; Shindo, A; Terada, S; Uchitomi, Y; Yokota, O | 1 |
| Arima, K; Imabayashi, E; Ito, K; Matsuda, H; Nakata, Y; Omachi, Y; Sato, N; Shimano, Y | 1 |
| Arnulf, I; Habert, MO; Kas, A; Lavault, S | 1 |
| Anderson, GM; Baguley, TD; Brouillette, J; Chatterjee, M; Cuny, GD; Ellman, JA; Foscue, E; Ghosh, D; Glicksman, MA; Greengard, P; Gresack, J; Kanyo, J; Kurup, P; Lam, TT; Lombroso, PJ; Nairn, AC; Ononenyi, C; Seyb, K; Tautz, L; Xu, J; Zhang, Y | 1 |
| Araki, T; Doi, H; Inamizu, S; Kira, J; Murai, H; Saito, BY | 1 |
| Chen, CY; Huang, CF; Lo, CP; Tu, MC | 1 |
| Chen, CY; Lo, CP; Tu, MC | 1 |
| Afshin-Majd, S; Baluchnejadmojarad, T; Kiasalari, Z; Roghani, M; Zarezadeh, M | 1 |
| Belin, C; Dumas, JL; Guillevin, L; Henegar, C; Lacau, C; Le Guern, V; Maillet, D; Moroni, C; Vigneron, N | 1 |
| Agosti, C; Alberici, A; Borroni, B; Di Luca, M; Grassi, M; Lucchini, S; Padovani, A; Paghera, B; Perani, D; Premi, E | 1 |
| Dubois, B; Fertil, B; Giron, A; Habert, MO; Horn, JF; Lotterie, JA; Mahieux, F; Onen, F; Portet, F; Puel, M; Sarazin, M; Touchon, J; Verny, M; Zanca, M | 1 |
| Hagino, H; Kawasaki, Y; Kobayashi, S; Kurachi, M; Maeno, N; Niu, L; Ozaki, N; Sasaoka, T; Seto, H; Suzuki, M; Takahashi, T; Tsuneki, H; Tsunoda, M; Zhou, SY | 1 |
| Khalsa, DS; Newberg, AB; Roggenkamp, H; Waldman, MR; Wintering, N | 1 |
| Bruno, G; Confaloni, A; Crestini, A; Gasparini, M; Lenzi, GL; Malvezzi-Campeggi, L; Piacentini, E; Piscopo, P; Talarico, G | 1 |
| Chang, CC; Chang, WN; Chen, C; Chen, CF; Huang, CW; Huang, SH; Lu, CH; Lui, CC; Tu, MC; Wang, JJ | 1 |
| Borghesani, PR; Borson, S; DeMers, SM; Lewis, DH; Manchanda, V; Pruthi, S | 1 |
| Bhalla, A; Gupta, N; Kohli, A; Mittal, T; Singh, B; Singh, S | 1 |
| Alberni, J; Ariza, M; Delgado, L; Garolera, M; Pardo, BM; Pareto, D; Salamero, M; Valles, V | 1 |
| Caso, F; Comi, G; Falautano, M; Magnani, G; Migliaccio, R; Onofrio, F; Perani, D; Todeschini, P | 1 |
| Dang-Vu, TT; Gagnon, JF; Gosselin, N; Montplaisir, J; Postuma, RB; Soucy, JP; Vendette, M | 1 |
| Chen, JJ; Ho, ST; Kao, A; Shiau, YC; Wang, JJ | 1 |
| Barabash, A; Cabranes, JA; De Juan, R; De Ugarte, C; Encinas, M; Fernández, C; Gil, P; Marcos, A | 2 |
| Almoguera, MI; Alonso-Farto, JC; Carol, N; Carreño, L; González, CM; López-Longo, FJ; Monteagudo, I; Olazarán, J; Ortega, A | 1 |
| Benoit, M; Clairet, S; Darcourt, J; Koulibaly, PM; Robert, PH | 1 |
| Anchisi, D; Borroni, B; Di Luca, M; Garibotto, V; Giubbini, R; Kerrouche, N; Padovani, A; Paghera, B; Perani, D; Terzi, A; Vicini, B; Vignolo, LA | 1 |
| Boronow, J; Dickerson, F; Origoni, A; Stallings, C; Yolken, R | 1 |
| Brockhuis, B; Derejko, M; Dubaniewicz, M; Lass, P; Sławek, J; Wieczorek, D | 1 |
| Satoh, T | 1 |
| Chang, CC; Chang, WN; Chang, YY; Chen, SS; Lee, CH; Liu, JS | 1 |
| De la Fuente, M; Frank, A; Hernanz, A; Navarro, M | 1 |
| Glaser, A; Herva, R; Ingelsson, M; Jönhagen, ME; Kalimo, H; Lannfelt, L; Skoglund, L; Viitanen, M | 1 |
| Driver, CB; Forbess, CJ; Lee, JC; Minoshima, S; Pourrabbani, S; Wallace, DJ; Waxman, AD; Weisman, MH | 1 |
| Kawasaki, Y | 1 |
| Andersen, AR; Bigelow, R; Hasselbalch, SG; Joseph, JL; Lassen, NA; Paulson, OB; Waldemar, G; Walovitch, RC | 1 |
| Bahia, VS; Buchpiguel, CA; Caixeta, L; Caramelli, P; Degenszajn, J; Mathias, SC; Nascimento, CM; Nitrini, R | 1 |
| Antonini, A; Benti, R; De Gaspari, D; De Notaris, R; Pezzoli, G | 1 |
1 review(s) available for cysteine and Cognition Disorders
| Article | Year |
|---|---|
[Cysteine-mediated signaling pathway by a novel electrophilic compound, NEPP11].
Topics: Cognition Disorders; Cysteine; Drug Design; Electrons; Neurodegenerative Diseases; Nitric Oxide; Prostaglandin D2; Prostaglandins; Signal Transduction | 2007 |
7 trial(s) available for cysteine and Cognition Disorders
| Article | Year |
|---|---|
Survival in frontotemporal lobar degeneration and related disorders: latent class predictors and brain functional correlates.
Topics: Adult; Aged; Brain; Cognition Disorders; Cysteine; Dementia; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Prognosis; Radioactive Tracers; Severity of Illness Index; Survival Rate | 2009 |
Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Diagnosis, Computer-Assisted; Disease Progression; Female; Humans; Linear Models; Longitudinal Studies; Male; Neuropsychological Tests; Organotechnetium Compounds; Perfusion; Tomography, Emission-Computed, Single-Photon | 2011 |
Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: a preliminary study.
Topics: Aged; Brain Mapping; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Humans; Male; Memory Disorders; Mental Status Schedule; Middle Aged; Negotiating; Neuropsychological Tests; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon | 2010 |
Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Disease Progression; Female; Humans; Longitudinal Ligaments; Male; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tomography, Emission-Computed, Single-Photon | 2003 |
Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
Topics: Alzheimer Disease; Cognition Disorders; Cysteine; Humans; Image Interpretation, Computer-Assisted; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2006 |
99mTc-bicisate (neurolite) SPECT brain imaging and cognitive impairment in dementia of the Alzheimer type: a blinded read of image sets from a multicenter SPECT trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition Disorders; Cysteine; Female; Humans; Male; Mental Status Schedule; Middle Aged; Organotechnetium Compounds; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 1994 |
SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Cysteine; Double-Blind Method; Female; Functional Laterality; Humans; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Parietal Lobe; Radiopharmaceuticals; Severity of Illness Index; Technetium Tc 99m Exametazime; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2000 |
31 other study(ies) available for cysteine and Cognition Disorders
| Article | Year |
|---|---|
Increased serum levels of cysteine in patients with schizophrenia: A potential marker of cognitive function preservation.
Topics: Adult; Aged; Blood Glucose; Case-Control Studies; Cognition Disorders; Cross-Sectional Studies; Cysteine; Executive Function; Fasting; Female; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Verbal Learning | 2018 |
Improvement of higher brain dysfunction after brain injury by repetitive transcranial magnetic stimulation and intensive rehabilitation therapy: case report.
Topics: Aged; Brain Injuries; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Electroencephalography; Functional Laterality; Humans; Male; Memory Disorders; Organotechnetium Compounds; Physical Conditioning, Human; Radiopharmaceuticals; Recovery of Function; Tomography, Emission-Computed, Single-Photon; Transcranial Magnetic Stimulation | 2017 |
Trail making test B and brain perfusion imaging in mild cognitive impairment and mild Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Humans; Male; Organotechnetium Compounds; Perfusion Imaging; Psychiatric Status Rating Scales; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Trail Making Test | 2013 |
Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition Disorders; Cysteine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2014 |
Feeling unreal: a functional imaging study in patients with Kleine-Levin syndrome.
Topics: Adolescent; Adult; Brain; Brain Mapping; Child; Cognition Disorders; Cysteine; Emotions; Female; Humans; Image Processing, Computer-Assisted; Kleine-Levin Syndrome; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Retrospective Studies; Severity of Illness Index; Statistics as Topic; Tomography, Emission-Computed, Single-Photon; Young Adult | 2014 |
Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Sequence; Animals; Benzothiepins; Catalytic Domain; Cell Death; Cerebral Cortex; Cognition Disorders; Cysteine; Disease Models, Animal; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Neurons; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases, Non-Receptor; Substrate Specificity | 2014 |
Analysis of cerebral lobar microbleeds and a decreased cerebral blood flow in a memory clinic setting.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Frontal Lobe; Humans; Intracranial Hemorrhages; Japan; Magnetic Resonance Imaging; Male; Organotechnetium Compounds; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon | 2015 |
Correlation of Tc-99 m ethyl cysteinate dimer single-photon emission computed tomography and clinical presentations in patients with low cobalamin status.
Topics: Adult; Aged; Aged, 80 and over; Brain; Cognition Disorders; Cognitive Dysfunction; Cysteine; Executive Function; Female; Humans; Male; Mental Disorders; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Vitamin B 12 Deficiency | 2015 |
Tc-99m-ECD SPECT as the measure for therapeutic response in patients with cobalamin deficiency: Two case reports.
Topics: Aged; Cognition Disorders; Cysteine; Female; Gyrus Cinguli; Humans; Middle Aged; Organotechnetium Compounds; Prefrontal Cortex; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vitamin B 12; Vitamin B 12 Deficiency; Vitamins | 2016 |
Garlic active constituent s-allyl cysteine protects against lipopolysaccharide-induced cognitive deficits in the rat: Possible involved mechanisms.
Topics: Acetylcholinesterase; Animals; Avoidance Learning; Biomarkers; Calcium-Binding Proteins; Cognition Disorders; Cysteine; Discrimination, Psychological; Garlic; Glial Fibrillary Acidic Protein; Hippocampus; Interleukin-1beta; Lipopolysaccharides; Male; Maze Learning; Memory; Microfilament Proteins; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Spatial Behavior; Toll-Like Receptor 4 | 2017 |
Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren syndrome: a case-control study.
Topics: Adolescent; Adult; Brain; Case-Control Studies; Cognition Disorders; Cysteine; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Radiopharmaceuticals; Sjogren's Syndrome; Tomography, Emission-Computed, Single-Photon | 2010 |
The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain morphology in schizophrenia.
Topics: Adult; Brain; Cognition Disorders; Cysteine; Female; Frontal Lobe; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Homozygote; Humans; Magnetic Resonance Imaging; Male; Nerve Tissue Proteins; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia; Schizophrenic Psychology; Serine | 2009 |
A novel mutation in the predicted TMIII domain of the PSEN2 gene in an Italian pedigree with atypical Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Cysteine; DNA Mutational Analysis; Female; Humans; Italy; Male; Middle Aged; Mutation; Neuropsychological Tests; Pedigree; Presenilin-2; Protein Structure, Tertiary; Serine | 2010 |
Multi-parametric neuroimaging evaluation of cerebrotendinous xanthomatosis and its correlation with neuropsychological presentations.
Topics: Adult; Brain; Case-Control Studies; Cognition Disorders; Cysteine; Diffusion Tensor Imaging; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Intellectual Disability; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon; Xanthomatosis, Cerebrotendinous | 2010 |
Neuroimaging in the clinical diagnosis of dementia: observations from a memory disorders clinic.
Topics: Aged; Brain; Cerebrovascular Disorders; Cognition Disorders; Cysteine; Dementia; Humans; Lewy Bodies; Magnetic Resonance Imaging; Oximes; Radiopharmaceuticals; Retrospective Studies; Technetium; Tomography, Emission-Computed, Single-Photon | 2010 |
Correlation of defects in regional cerebral blood flow determined by 99mTc SPECT with residual neurocognitive testing abnormalities during and 3 months post exposure in acutely poisoned patients with organophosphates.
Topics: Acute Disease; Adolescent; Adult; Brain; Cerebrovascular Circulation; Cholinergic Antagonists; Cognition Disorders; Cysteine; Female; Humans; Insecticides; Male; Memory; Middle Aged; Neuropsychological Tests; Organophosphate Poisoning; Organotechnetium Compounds; Poisoning; Psychomotor Performance; Radiopharmaceuticals; Recognition, Psychology; Suicide, Attempted; Tomography, Emission-Computed, Single-Photon; Trail Making Test; Verbal Behavior; Young Adult | 2011 |
Improvement of cognitive flexibility and cingulate blood flow correlates after atypical antipsychotic treatment in drug-naive patients with first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Brain Mapping; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Organotechnetium Compounds; Psychiatric Status Rating Scales; Schizophrenia; Statistics as Topic; Tomography, Emission-Computed, Single-Photon; Young Adult | 2011 |
From primary progressive aphasia to corticobasal syndrome: two clinical and rCBF functional reports.
Topics: Aged; Aphasia, Primary Progressive; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Humans; Longitudinal Studies; Neuropsychological Tests; Organotechnetium Compounds; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2013 |
Brain perfusion anomalies in rapid eye movement sleep behavior disorder with mild cognitive impairment.
Topics: Aged; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Perfusion; Polysomnography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon | 2012 |
Abnormal regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with normal magnetic resonance imaging findings. A preliminary report.
Topics: Adult; Antiphospholipid Syndrome; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2002 |
Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage.
Topics: Adolescent; Adult; Aged; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2003 |
Relevance of functional neuroimaging in the progression of mild cognitive impairment.
Topics: Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Disease Progression; Follow-Up Studies; Humans; Logistic Models; Longitudinal Studies; Neuropsychological Tests; Organotechnetium Compounds; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Tomography, Emission-Computed, Single-Photon | 2004 |
Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Humans; Middle Aged; Mood Disorders; Motivation; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon | 2004 |
The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia.
Topics: Adult; Antibodies, Viral; Arginine; Bipolar Disorder; Cognition Disorders; Cysteine; Female; Genetic Predisposition to Disease; Genotype; Herpesvirus 1, Human; Humans; Intelligence; Lymphotoxin-alpha; Male; Middle Aged; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia | 2007 |
Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
Topics: Aged; Aged, 80 and over; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Parkinson Disease; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
(99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests.
Topics: Aged; Aged, 80 and over; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Parkinson Disease; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2008 |
Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognition Disorders; Cysteine; Down-Regulation; Female; Glutathione; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Receptors, Tumor Necrosis Factor, Type II; Sulfhydryl Compounds; Up-Regulation | 2007 |
The tau S305S mutation causes frontotemporal dementia with parkinsonism.
Topics: Adult; Amino Acid Substitution; Behavior; Brain; Cognition Disorders; Cysteine; Dementia; Humans; Male; Mutation; Parkinsonian Disorders; Pedigree; Personality; Phenotype; Protein Isoforms; tau Proteins; Threonine | 2008 |
Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Cognition Disorders; Cysteine; Female; Frontal Lobe; Humans; Lupus Vasculitis, Central Nervous System; Middle Aged; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon | 2008 |
[Advance prediction of Mild Cognitive Impairment (MCI) using (99m)Tc-ECD SPECT brain blood flow imaging].
Topics: Alzheimer Disease; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Humans; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease.
Topics: Aged; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Frontal Lobe; Humans; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Parkinson Disease; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2001 |